A total of 16 patients showed a PSA level above 4 ng/mL and this incidence of increase is 33.33% (16/48) vs 6.7% in the general population (4), among whom five had prostate cancer, as established by transrectal ultrasound biopsy (Table 2). The gene discussed is KLK3; the disease is prostate carcinoma.